MDFondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, ItalyMilan, Lombardia, Italy
OC 26.2 - Bortezomib for rituximab-refractory immune-mediated thrombotic thrombocytopenic purpura in the caplacizumab era: update of an Italian multicenter study
Sunday, June 23, 202415:00 – 15:15 ICT
OC 26.5 - Predisposing conditions and drugs to caplacizumab-related bleeding episodes in patients with acute immune-mediated TTP: real-world data from the Milan Center
Sunday, June 23, 202415:45 – 16:00 ICT
PB1326 - Clinical severity of the first episode and risk of recurrent neurological symptoms in relapses among patients with immune-mediated thrombotic thrombocytopenic purpura
Tuesday, June 25, 202413:45 – 14:45 ICT
